期刊文献+

前列腺癌放射治疗 被引量:1

原文传递
导出
摘要 前列腺癌是男性生殖泌尿系统常见的恶性肿瘤之一,近年,随着人们生活水平的提高,前列腺癌的发病率也在不断提高。在美国,前列腺癌发病率居男性肿瘤第1位,发病率在100/10万以上,病死率居第2位。中国前列腺癌发病率和病死率呈上升趋势回。在中国男性肿瘤中,前列腺癌发病率居第11位,病死率居第16位。目前中国前列腺癌发病率正在不断升高。众多研究表明,放射治疗对局部晚期前列腺癌的治疗效果较好,对部分已有远处转移的前列腺癌也有一定疗效。本文就前列腺癌放射治疗现状及进展作如下综述。
作者 侯旭 王相平
出处 《中国医师进修杂志》 2012年第26期72-74,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献15

二级参考文献134

  • 1房辉,李晔雄.前列腺癌的适形和调强适形放疗[J].癌症进展,2005,3(5):449-460. 被引量:10
  • 2赵献光,于素娟,于金明,郑爱青,黎功,常新忠.三维适形放疗加内分泌治疗中晚期前列腺癌32例临床分析[J].中华泌尿外科杂志,2006,27(1):49-51. 被引量:9
  • 3余子豪.前列腺癌的三维适形或调强适形放射治疗[J].中华泌尿外科杂志,2006,27(9):647-648. 被引量:12
  • 4唐鑫.前列腺癌的放射治疗[J].临床军医杂志,2007,35(1):107-111. 被引量:16
  • 5Vicini FA,Kini VR,Spencer W,et al.The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy.Int J Radiat Oncol Biol Phys,1999,43:707-713.
  • 6Schwarz R.Curative radiotherapy of localized prostate cancer.Treatment methods and results.Urologe A ,2003,42:1212-1220.
  • 7Sumi M,Ikeda H,Tokuuye K,et al.The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma.Int J Radiat Oncol Biol Phys,2000,48:519-528.
  • 8Bolla M,Collette L,Blank L,et al.Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer(an EORTC study) :a phase Ⅲ randomised trial.Lancet ,2002,360:103-106.
  • 9Greco C,Mazzetta C,Cattani F,et al.Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.Radiother Oncol,2003,69:215-222.
  • 10Zelefsky MJ, Levin E J, Hunt M,et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer[ J ]. Int J Radiat Oncol Biol Phys, 2008,70 ( 4 ) : 1124 - 1129.

共引文献54

同被引文献13

  • 1Sharkey J, Cantor A, Sole Z, et al. 103Pd brachytherapy versusradical prostatectomy in patients with clinically localized prostatecancer : a 12-year experience from a single group practice. Brachy-therapy ,2005 ,4( 1) :34-44.
  • 2Cockshott ID. Bicalutamide: clinical pharmacokinetics and metabo-lism. Clin Pharmacokinet, 2004,43 (13) : 855-878.
  • 3McLeod DG, Iversen P, See WA, et al. Bicalutamide 150 mg plusstandard care vs standard care alone for early prostate cancer. BJUInt, 2006,97(2):247-254.
  • 4Albrecht W, Collette L, Fava C, et al. Intermittent maximal andro-gen blockade in patients with metastatic prostate cancer: an EORTCfeasibility study. Eur Urol, 2003,44(5) :505-511.
  • 5Akaza H. Combined androgen blockade for prostate cancer: reviewof efficacy, safety and cost-effectiveness. Cancer Sci, 2011,102(1):51-56.
  • 6Wirth MP, See WA, McLeod DG, et al. Bicalutamide 150 mg inaddition to standard care in patients with localized or locally ad-vanced prostate cancer: results from the second analysis of the earlyprostate cancer program at median followup of 5. 4 years. J Urol,2004,172(5 Pt 1):1865-1870.
  • 7Iversen P, Johansson JE, Lodding P, et al. Bicalutamide ( 150mg) versus placebo as immediate therapy alone or as adjuvant totherapy with curative intent for early nonmetastatic prostate cancer :5. 3-year median followup from the Scandinavian Prostate CancerGroup Study Number 6. J Urol, 2004,172(5 Pt 1) : 1871-1876.
  • 8霍立志,程镇,王腾春,石汝骥,井汉国,闫会秋.总前列腺特异抗原与游离前列腺特异抗原及其比值在前列腺癌鉴别诊断中的价值[J].中国医药,2011,6(1):78-79. 被引量:9
  • 9沈杰,康健,叶敏,陈建华,俞奇伟,包卫东,齐隽.高危前列腺癌间歇性和持续性内分泌治疗的临床评价[J].中国医师进修杂志,2011,34(29):9-11. 被引量:3
  • 10郭彬,吴文起,卢小刚,钟东亮,单炽昌.腹腔镜前列腺癌射频消融术的应用研究[J].中国医师进修杂志,2011,34(29):14-16. 被引量:2

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部